Obesity Clinical Trial
— SNEEXOfficial title:
SNEEX - Impact of Olfactory Odour StimulatioN on Energy EXpenditure
| Verified date | December 2023 |
| Source | University Hospital, Basel, Switzerland |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
In this preliminary short-term study it is investigated, whether a short olfactory stimulation with distinct odours impacts energy expenditure in patients with obesity and lean patients.
| Status | Recruiting |
| Enrollment | 58 |
| Est. completion date | October 30, 2024 |
| Est. primary completion date | June 30, 2024 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 55 Years |
| Eligibility | Inclusion Criteria: - • Age 18-55 years - Obesity (BMI =30 kg/m2) and Lean (BMI 18-25 kg/m2) - Written informed consent - Normosmia (defined by sniffing Sticks test) Exclusion Criteria: - • Chronic or acute sinusitis - Surgical intervention of the nasal cavity or the paranasal sinus - Known allergy to odors used in the study - Smokers - Current illicit drug abuse including daily marijuana and cannabidiol (CBD) consumption (alcohol =2 drinks per day allowed) - Any kind of severe chronic disease (e.g. severe heart failure, active cancer disease) - Diabetes mellitus - Treatment with insulin sensitizing drugs including Glucagon-like Peptide (GLP)-1 analogues within the last 3 months - History of neurodegenerative diseases, severe head trauma - Severe renal impairment (e.g. estimated glomerular filtration rate <30 ml/min/m2) - Known liver cirrhosis or other severe liver impairment - Use of any kind of decongestant more than twice a week - Use of cortisone-containing nasal spray within the last 3 months - Acute upper respiratory tract infection - Uncontrolled dysthyroidism - Uncontrolled hypertension - Regular use of psychopharmaceutic drugs - Study participants aims to start a new diet or exercise program during the study - Bariatric surgery - Pregnancy/Lactation - Onset of climacteric symptoms within one year (e.g. hot flashes and/or diaphoresis) OR initiation of hormonal replacement therapy in the last three months - Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. - Participation in an interventional study within the last 3 months |
| Country | Name | City | State |
|---|---|---|---|
| Switzerland | University Hospital Basel | Basel |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Basel, Switzerland |
Switzerland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in Energy Expenditure | change in energy expenditure as assessed via calorimetry after olfactory stimulation with different odours. | 6 hours | |
| Secondary | Energy Expenditure, Additional Odours | Change in energy expenditure as assessed via calorimetry after olfactory stimulation with Different odours | 6 hours | |
| Secondary | Heart Rate | change in heart rate variability upon olfactory stimulation with different odors as assessed via continuous ECG | 6 hours | |
| Secondary | Blood Pressure | Change in blood pressure upon olfactory stimulation with different odors as assessed via a blood pressure cuff at the upper arm according to Riva Rocci | 6 hours | |
| Secondary | Metabolic Parameters | Change in metabolic blood parameters upon acute olfactory stimulation with different odours | 6 hours | |
| Secondary | Glucose Levels | change in interstitial fluid glucose levels upon olfactory stimulation with different odours | 6 hours |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |